267 related articles for article (PubMed ID: 25214541)
1. A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.
Findlay JM; Middleton MR; Tomlinson I
Ann Oncol; 2015 Apr; 26(4):624-644. PubMed ID: 25214541
[TBL] [Abstract][Full Text] [Related]
2. Systematic Review: Genetic Associations for Prognostic Factors of Urinary Bladder Cancer.
Lipunova N; Wesselius A; Cheng KK; van Schooten FJ; Cazier JB; Bryan RT; Zeegers MP
Biomark Cancer; 2019; 11():1179299X19897255. PubMed ID: 31908559
[TBL] [Abstract][Full Text] [Related]
3. Genomics of Cancer and a New Era for Cancer Prevention.
Brennan P; Wild CP
PLoS Genet; 2015 Nov; 11(11):e1005522. PubMed ID: 26540230
[TBL] [Abstract][Full Text] [Related]
4.
Meng XY
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37277194
[No Abstract] [Full Text] [Related]
5. New concepts in breast cancer genomics and genetics.
Goncalves R; Warner WA; Luo J; Ellis MJ
Breast Cancer Res; 2014; 16(5):460. PubMed ID: 25606588
[TBL] [Abstract][Full Text] [Related]
6. Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.
Yang R; Zhang C; Malik A; Shen ZD; Hu J; Wu YH
World J Gastroenterol; 2014 Nov; 20(44):16765-73. PubMed ID: 25469049
[TBL] [Abstract][Full Text] [Related]
7. Predicting response to neoadjuvant therapy in esophageal cancer with p53 genotyping: a fortune-teller's crystal ball or a viable prognostic tool?
Nason KS
J Thorac Cardiovasc Surg; 2014 Nov; 148(5):2286-7. PubMed ID: 25444198
[No Abstract] [Full Text] [Related]
8. Targeting the DNA replication checkpoint by pharmacologic inhibition of Chk1 kinase: a strategy to sensitize APC mutant colon cancer cells to 5-fluorouracil chemotherapy.
Martino-Echarri E; Henderson BR; Brocardo MG
Oncotarget; 2014 Oct; 5(20):9889-900. PubMed ID: 25301724
[TBL] [Abstract][Full Text] [Related]
9. Systematic Functional Annotation of Somatic Mutations in Cancer.
Ng PK; Li J; Jeong KJ; Shao S; Chen H; Tsang YH; Sengupta S; Wang Z; Bhavana VH; Tran R; Soewito S; Minussi DC; Moreno D; Kong K; Dogruluk T; Lu H; Gao J; Tokheim C; Zhou DC; Johnson AM; Zeng J; Ip CKM; Ju Z; Wester M; Yu S; Li Y; Vellano CP; Schultz N; Karchin R; Ding L; Lu Y; Cheung LWT; Chen K; Shaw KR; Meric-Bernstam F; Scott KL; Yi S; Sahni N; Liang H; Mills GB
Cancer Cell; 2018 Mar; 33(3):450-462.e10. PubMed ID: 29533785
[TBL] [Abstract][Full Text] [Related]
10. Next-generation sequencing reveals gene mutations landscape and clonal evolution in patients with acute myeloid leukemia.
Chen X; Zhu H; Qiao C; Zhao S; Liu L; Wang Y; Jin H; Qian S; Wu Y
Hematology; 2021 Dec; 26(1):111-122. PubMed ID: 33491606
[TBL] [Abstract][Full Text] [Related]
11. Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation.
Wang K; Zhou F; Cai X; Chao H; Zhang R; Chen S
Hematology; 2020 Dec; 25(1):211-218. PubMed ID: 32476595
[No Abstract] [Full Text] [Related]
12. DNA-Repair Gene Mutations Are Highly Prevalent in Circulating Tumour DNA from Multiple Myeloma Patients.
Mithraprabhu S; Hocking J; Ramachandran M; Choi K; Klarica D; Khong T; Reynolds J; Spencer A
Cancers (Basel); 2019 Jun; 11(7):. PubMed ID: 31261969
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature.
Kuendgen A; Müller-Thomas C; Lauseker M; Haferlach T; Urbaniak P; Schroeder T; Brings C; Wulfert M; Meggendorfer M; Hildebrandt B; Betz B; Royer-Pokora B; Gattermann N; Haas R; Germing U; Götze KS
Oncotarget; 2018 Jun; 9(45):27882-27894. PubMed ID: 29963245
[TBL] [Abstract][Full Text] [Related]
14. Mutations and prognosis in myelodysplastic syndromes: karyotype-adjusted analysis of targeted sequencing in 300 consecutive cases and development of a genetic risk model.
Gangat N; Mudireddy M; Lasho TL; Finke CM; Nicolosi M; Szuber N; Patnaik MM; Pardanani A; Hanson CA; Ketterling RP; Tefferi A
Am J Hematol; 2018 May; 93(5):691-697. PubMed ID: 29417633
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes.
Cedena MT; Rapado I; Santos-Lozano A; Ayala R; Onecha E; Abaigar M; Such E; Ramos F; Cervera J; Díez-Campelo M; Sanz G; Rivas JH; Lucía A; Martínez-López J
Oncotarget; 2017 Dec; 8(63):106948-106961. PubMed ID: 29291002
[TBL] [Abstract][Full Text] [Related]
16. RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features.
Gaidzik VI; Teleanu V; Papaemmanuil E; Weber D; Paschka P; Hahn J; Wallrabenstein T; Kolbinger B; Köhne CH; Horst HA; Brossart P; Held G; Kündgen A; Ringhoffer M; Götze K; Rummel M; Gerstung M; Campbell P; Kraus JM; Kestler HA; Thol F; Heuser M; Schlegelberger B; Ganser A; Bullinger L; Schlenk RF; Döhner K; Döhner H
Leukemia; 2016 Nov; 30(11):2160-2168. PubMed ID: 27137476
[TBL] [Abstract][Full Text] [Related]
17. Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutations.
Hamilton BK; Visconte V; Jia X; Tabarroki A; Makishima H; Hasrouni E; Abounader D; Kalaycio M; Sekeres MA; Sobecks R; Duong Liu H; Bolwell B; Maciejewski JP; Copelan E; Tiu RV
Am J Hematol; 2016 Jun; 91(4):406-9. PubMed ID: 26799334
[TBL] [Abstract][Full Text] [Related]
18. Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors.
Zhang X; Wang Y; Zhang X; Shen Y; Yang K; Ma Q; Qiao Y; Shi J; Wang Y; Xu L; Yang B; Ge G; Hu L; Kong X; Yang C; Chen Y; Ding J; Meng L
Signal Transduct Target Ther; 2023 Apr; 8(1):153. PubMed ID: 37041169
[TBL] [Abstract][Full Text] [Related]
19. Current and Future Immunotherapy-Based Treatments for Oesophageal Cancers.
To N; Evans RPT; Pearce H; Kamarajah SK; Moss P; Griffiths EA
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804876
[TBL] [Abstract][Full Text] [Related]
20. CENPA promotes clear cell renal cell carcinoma progression and metastasis via Wnt/β-catenin signaling pathway.
Wang Q; Xu J; Xiong Z; Xu T; Liu J; Liu Y; Chen J; Shi J; Shou Y; Yue C; Liu D; Liang H; Yang H; Yang X; Zhang X
J Transl Med; 2021 Oct; 19(1):417. PubMed ID: 34627268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
